2025 Oncology Institute
April 19, 2025 | 8:05 PM EST
- Home
- Clinical Resources Search
- PQI in Action: Oral Formulation of Decitabine and Cedazuridine (Inqovi®) for Hematological Malignancies
Oral Formulation of Decitabine and Cedazuridine (Inqovi®) for Hematological Malignancies
Download PQI pdf 3.04MB
Last Updated: November 1, 2024
By: Hematology-Oncology Associates of Central New York, NY | McFarland Clinic, IA
About this PQI in Action
This PQI in Action is a follow up to the Oral Formulation of Decitabine and Cedazuridine (Inqovi®) for Hematological Malignancies PQIand explores how the medically integrated teams at Hematology-Oncology Associates of Central New York (HOACNY) and the McFarland Clinic collaborate and utilize the information found in the PQI as part of their daily practice. This article will discuss how utilizing the Oral Formulation of Decitabine and Cedazuridine (Inqovi®) for Hematological Malignancies PQI elevates patient care.
More About This PQI in Action
Find a PQIPQI in Action
PQI in Action: Oral Formulation of Decitabine and Cedazuridine (Inqovi®) for Hematological Malignancies
Last Updated: November 1, 2024
PQI
PQI: Oral Formulation of Decitabine and Cedazuridine (Inqovi®) for Hematological Malignancies
Last Updated: November 14, 2023